What is the most likely diagnosis and recommended treatment for a non‑pruritic, reticulated or hypopigmented macular rash confined to the abdomen and flank?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tinea Versicolor (Pityriasis Versicolor)

The most likely diagnosis is tinea versicolor (pityriasis versicolor), a superficial fungal infection caused by Malassezia species that characteristically presents as hypopigmented, reticulated, non-pruritic macules on the trunk and should be treated with topical ketoconazole 2% cream applied once daily for two weeks. 1, 2

Clinical Diagnosis

  • Tinea versicolor characteristically presents as scaly hypopigmented or hyperpigmented macules/patches primarily located on the upper trunk, neck, and upper arms—exactly matching this patient's distribution on abdomen and flank. 2

  • The non-pruritic nature is typical, as tinea versicolor is generally asymptomatic or minimally symptomatic. 3

  • The reticulated or hypopigmented appearance is pathognomonic for the hypopigmented variant (pityriasis versicolor alba), which occurs when fungal metabolites inhibit melanin synthesis. 4

  • Diagnosis is usually made clinically based on characteristic features without requiring laboratory confirmation. 2

  • If diagnostic uncertainty exists, potassium hydroxide (KOH) preparation reveals numerous short, stubby hyphae intermixed with clusters of spores ("spaghetti and meatballs" appearance). 2

First-Line Treatment

Topical antifungal therapy is the treatment of choice due to better safety profile, fewer adverse events, fewer drug interactions, and lower cost compared to systemic treatment. 2, 5

  • Apply ketoconazole 2% cream once daily to the affected area and immediate surrounding skin for two weeks to reduce recurrence risk. 1

  • Alternative topical options include zinc pyrithione shampoo, selenium sulfide, or terbinafine cream. 5, 6

  • Clinical improvement may be seen fairly soon after treatment begins, but the full two-week course is essential to prevent recurrence. 1

When to Consider Oral Therapy

Oral antifungal therapy should be reserved for specific situations: 2, 5

  • Extensive disease covering large body surface areas
  • Frequent recurrences despite topical therapy
  • Disease refractory to adequate topical treatment
  • Patient preference when compliance with topical therapy is poor

If oral therapy is indicated, use either itraconazole or fluconazole—oral ketoconazole should no longer be prescribed due to hepatotoxicity risk, and oral terbinafine is ineffective for tinea versicolor. 5

Critical Management Pitfalls

  • The hypopigmentation may persist for weeks to months after successful fungal eradication, as repigmentation requires time for melanocyte recovery and new melanin synthesis. 4

  • Patients must understand that clearing the infection does not immediately restore normal pigmentation—this prevents premature discontinuation of therapy or unnecessary retreatment. 4

  • Recurrence rates are high (up to 60% within one year) because Malassezia species are part of normal skin flora. 2, 6

  • Long-term intermittent prophylactic therapy should be considered for patients with frequent recurrences, such as monthly application of topical antifungals or periodic oral therapy. 5, 6

Differential Considerations to Exclude

While tinea versicolor is the clear diagnosis here, briefly consider:

  • Vitiligo presents with complete depigmentation (not hypopigmentation) and lacks the fine scale characteristic of tinea versicolor. 3

  • Post-inflammatory hypopigmentation requires a history of preceding inflammatory dermatosis. 3

  • Pityriasis alba occurs primarily on the face in children and has less distinct borders. 3

  • The non-pruritic nature and trunk distribution exclude inflammatory conditions like eczema or psoriasis. 2

References

Research

Tinea versicolor: an updated review.

Drugs in context, 2022

Research

Pityriasis versicolor alba.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2005

Research

Antifungal Treatment for Pityriasis Versicolor.

Journal of fungi (Basel, Switzerland), 2015

Research

Management of seborrheic dermatitis and pityriasis versicolor.

American journal of clinical dermatology, 2000

Related Questions

What is tinea versicolor?
Can tinea versicolor cause itching?
What antifungal (anti-fungal) treatments are effective for tinea versicolor?
What is the underlying mechanism of a 17-year-old boy's nonpruritic, hypopigmented macules on the chest and trunk, with fine scaling, after returning from Puerto Rico and starting a new laundry detergent, with a history of type 1 diabetes mellitus (T1DM) and family history of Hashimoto thyroiditis and acne?
What are the treatment options for Tinea versicolor, including antifungal (anti-fungal) medications?
What is the recommended acute management for Bell's palsy, including corticosteroid dosing, antiviral indications, eye protection, analgesia, facial exercises, follow‑up, and contraindication considerations?
What is the recommended first‑line treatment for uncomplicated genital Chlamydia trachomatis infection in non‑pregnant adults, and what are the preferred regimens for pregnant or lactating patients and for patients who cannot take doxycycline?
In a 55-year-old man with liver cirrhosis presenting with hepatic encephalopathy and tense ascites, what is the most appropriate initial management?
Is cefotazidime‑avibactam appropriate for treating tracheobronchitis caused by Klebsiella pneumoniae producing a broad‑spectrum β‑lactamase in an adult with normal renal function?
Is there any association between the shingles vaccines (Zostavax [live‑attenuated varicella‑zoster vaccine] or Shingrix [recombinant zoster vaccine]) and paronychia?
When should prazosin be prescribed for persistent nightmares in an adult patient with post‑traumatic stress disorder who has not responded to first‑line therapies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.